AZD5312
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD5312, covering 2016-07-14 to 2016-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors [Phase 1]